To visit the old Ventura website, click here.
Ventura Wealth Clients Login here
Refer and earnSupport
logosearch
Create Account
hamburger
home
breadcrumbStocks
breadcrumbKilitch Drugs India Ltd Share Price

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
AskQtyOrders

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

₹441.152 days ago
₹441.152 days ago
arrow

LOWER/UPPER CIRCUITS

₹441.15
₹459.15
arrow
Kilitch Drugs India Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral

Our researchers has found no immediate positive insights for this stock. We'll update this space as soon as we find something.

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 14.81%
Net profit growth 5Y CAGR : 96.79%

Similar stocks

Kilitch Drugs (India) Limited is an India-based company engaged in pharmaceutical business. The Company’s services range from manufacturing to marketing a host of formulations in all dosage forms such as solid liquid and parenteral forms. The Company is a manufacturer of antibacterial parenteral formulations. Its products include Carbapenems Cephalosporins Aminoglycosides anti malarials and other anti-infectives. The Company trades in Eyekare Pharmaceuticals products and is located in Mumbai. On February 28 2012 the Company discontinued its manufacturing activity at Paonta Sahib. The Company also transferred certain products by entering into a product transfer agreement with Akorn India Pvt. Ltd. (AIPL) by which the right to manufacture certain products by the Company at Mumbai were sold to AIPL.
personal

Grow your wealth with more research recommendations

+91